Oncotelic Therapeutics's total assets for Q2 2025 were $26.68M, an increase of 0.05% from the previous quarter. OTLC total liabilities were $19.29M for the fiscal quarter, a -1.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.